Corcept Therapeutics director James N. Wilson reports disposal of $726,677.9383 in common shares
CORT•Director James N. Wilson sold 10,000 Corcept Therapeutics common shares on Nov. 13, 2026, at reported prices ranging from $71.8011 to $74.28 per share.
1. Share sale
James N. Wilson sold 10,000 Corcept Therapeutics common shares on Nov. 13, 2026, at reported prices ranging from $71.8011 to $74.28 per share. After the sales, indirect holdings totaled 1,044,543 shares through a family trust, with another 400,000 shares held through two annuity trusts.




